<?xml version='1.0' encoding='utf-8'?>
<document id="24661191"><sentence text="Liver injury possibly related to drug interaction after liver transplant: a case report." /><sentence text="Drug-induced hepatotoxicity is potentially lethal" /><sentence text=" Liver transplant patients receive a large number of medications and adverse drug reactions, and drug-drug interactions must be closely monitored" /><sentence text="" /><sentence text="We report a case of a 29-year-old liver transplant patient who suffered liver injury most likely induced by drug interaction between capecitabine and warfarin"><entity charOffset="133-145" id="DDI-PubMed.24661191.s5.e0" text="capecitabine" /><entity charOffset="150-158" id="DDI-PubMed.24661191.s5.e1" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.24661191.s5.e0" e2="DDI-PubMed.24661191.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24661191.s5.e0" e2="DDI-PubMed.24661191.s5.e1" /></sentence><sentence text=" Vitamin K1 caused skin rash possibly because of the distribution and metabolism characteristic of the drug in this patient"><entity charOffset="1-11" id="DDI-PubMed.24661191.s6.e0" text="Vitamin K1" /></sentence><sentence text="" /><sentence text="Close monitoring and prompt discontinuation of the drugs with high volume of distribution and metabolized through the liver are necessary to avoid drug-drug interaction in liver transplant patients" /><sentence text="" /></document>